Le Lézard
Classified in: Health
Subject: NPT

Naturopathic Medicine Helps Address Anxiety Without Addictive Medications


WASHINGTON, Oct. 13, 2017 /PRNewswire-USNewswire/ -- Rosanna Blacker has suffered from anxiety since a very young age, but is now anxiety-free, exercising again, and back to her goal weight?all thanks to naturopathic medicine and without addictive prescription medications. We celebrate her success story this National Naturopathic Medicine Week, created by the United States Senate through its Resolution urging Americans to learn more about "the value of naturopathic medicine in providing safe, effective, and affordable health care."

 (PRNewsfoto/Institute for Natural Medicine)

After moving from Hawaii to Connecticut in February 2016, Rosanna had a panic attack while driving and began taking a number of medications to treat her anxiety. These treatments brought unwanted side effects, made her feel even more anxious, and forced her to stop teaching fitness classes. Then she went to see licensed naturopathic doctor Jaquel Patterson. Dr. Patterson helped her rebuild her health by integrating a complete holistic spectrum. Just two months after starting Dr. Patterson's personalized protocol, which combined supplements, herbal teas, homeopathy, acupuncture, nutrition, and exercise, Rosanna is now anxiety-free.

"What I appreciate the most about my naturopathic doctor is that she takes the time to really listen," says Rosanna. "She helped me understand that it is harder to build a healthy relationship with anxiety than just pop a pill; but it is totally worth it to find real healing with naturopathic medicine."

Following Dr. Patterson's personalized naturopathic medicine protocol, Rosanna, who is a master reiki and certified essential oils aroma therapist, now feels healthier than she has in a long time. She is even teaching yoga and pilates again.

Watch this video to learn more and read more success stories in the naturopathic medicine patient gallery.

About the Institute for Natural Medicine
The Institute for Natural Medicine (INM) is a national not-for-profit 501(c)(3) organization that provides public education about naturopathic medicine and increases consumer access to naturopathic doctors. As a close partner to the American Association of Naturopathic Physicians, the INM strives to increase consumer and physician choice in safe, effective healthcare that improves patient outcomes and lowers costs. For more information visit www.naturemed.org or call 855-799-4490.

About the AANP
The American Association of Naturopathic Physicians is the professional association that represents licensed naturopathic physicians. The AANP strives to make naturopathic medicine available to every American, and to increase recognition of naturopathic physicians as the identified authorities on natural medicine. Learn more at www.naturopathic.org.

 

Media Contact
Rob Wyse
[email protected]
212-920-1470

SOURCE Institute for Natural Medicine


These press releases may also interest you

at 10:31
Recently, GenScript Biotech Corporation (HK.1548), a world leader in technologies and services for life science R&D and manufacture, released its 2023 Environmental, Social, and Governance (ESG) report. This report showcases the company's dedicated...

at 10:30
Vaccines Market in terms of revenue was estimated to be worth $78.0 billion in 2024 and is poised to reach $94.9 billion by 2029, growing at a CAGR of 4.0% from 2024 to 2029 according to a new report by MarketsandMarketstm. Similarly, the vaccines...

at 10:25
Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through the development of potentially best-in-class IL-2 therapeutics, today announced that updated Phase 1/2 data for AU-007 will be presented at the American Society...

at 10:20
A monument park and website honoring medical frontline and essential workers worldwide who risked their lives during the COVID-19 pandemic will break ground this summer in Chicago, Illinois. The COVID-19 Monument of Honor, Remembrance, and Resilience...

at 10:20
Precigen, Inc. , a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced clinical data from the pivotal Phase 2 study of PRGN-2012 AdenoVerse immunotherapy...

at 10:20
The two poster presentations will report -first combination data from the Phase 1/2a study with BI-1808 in combination with MSD's anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), as well as an update on monotherapy armcombination data from the...



News published on and distributed by: